Driehaus Capital Management LLC Kymera Therapeutics, Inc. Transaction History
Driehaus Capital Management LLC
- $10.3 Billion
- Q4 2024
A detailed history of Driehaus Capital Management LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 1,390,372 shares of KYMR stock, worth $41.2 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
1,390,372
Previous 1,328,703
4.64%
Holding current value
$41.2 Million
Previous $62.9 Million
11.06%
% of portfolio
0.54%
Previous 0.62%
Shares
8 transactions
Others Institutions Holding KYMR
# of Institutions
185Shares Held
60.3MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$203 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$178 Million2.67% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$153 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$153 Million3.02% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$145 Million32.49% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.62B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...